Is PACS Group (PACS) the Cheap New Stock to Buy Right Now?

We recently published a list of 10 Cheap New Stocks To Buy Right Now. In this article, we are going to take a look at where PACS Group Inc. (NYSE:PACS) stands against other cheap new stocks to buy right now.

The US IPO market experienced a rebound in 2024, with proceeds and deal volume increasing as compared to the previous two years. However, activity remained below historical levels due to economic uncertainty. A resurgence is expected in 2025, mainly driven by potential interest rate cuts, pent-up investor demand, and a large pipeline of well-prepared companies, including many unicorns. This was discussed in detail earlier in our 12 Best New Stocks to Buy According to Hedge Funds article. Here’s an excerpt from it:

“…IPO activity saw a strong increase in 2024, with 61 traditional IPOs garnering more than $26.4 billion YTD, which was in line with the combined total number of IPOs in 2022 and 2023, which witnessed 28 and 35 IPOs, respectively. Despite this improvement, IPO activity remained short of early anticipations and historical levels of activity. This is because several IPO candidates decided to stay on the sidelines as they waited for a clearer economic picture after the U.S. presidential elections.”

General Atlantic CEO Bill Ford recently joined CNBC’s ‘Squawk Box’ to discuss the state of the private equity landscape, the IPO market, and the M&A outlook for 2025. Speaking on January 21, Ford highlighted that the IPO market has faced challenges over the past three years due to regulatory hurdles and a difficult exit environment. Despite this, there’s optimism about a renaissance in IPO activity, with 28 companies in General Atlantic’s pipeline ready to go public. This resurgence is anticipated to benefit private equity investors seeking liquidity, companies looking to raise capital, and public investors eager to access high-growth opportunities.

Ford noted that the regulatory overhang from the previous administration had discouraged many companies from pursuing public listings despite favorable equity markets and a strong economy. However, as these barriers begin to ease, he expects a wave of IPOs that will reinvigorate the public markets. He described this development as a triple win, enabling private equity firms to achieve liquidity, providing growth-stage companies with much-needed capital, and offering public investors access to innovative businesses. The discussion also touched on the broader implications for private equity. Ford explained that while strategic buyers had been sidelined in recent years due to regulatory constraints, their return to the market could create a more balanced environment. Historically, about 50% of exits occurred through IPOs and 50% through M&A transactions, and Ford anticipates a return to this equilibrium.

Ford’s comments align with broader trends in the IPO landscape for 2025. A lot of companies have signaled intentions to go public this year, reflecting renewed confidence in public markets. This revival is expected to reshape the investment landscape.

Methodology

We used the Finviz stock screener to look for companies that went public in the past 2 years. We sorted our screen by IPO date and market cap and looked through the top stocks that recently went public and are trading at a valuation of over $1 billion. We then selected 10 stocks with a forward P/E ratio under 15, that were the most popular among elite hedge funds and that analysts were bullish on. The stocks are ranked in ascending order of the number of hedge funds that have stakes in them, as of Q3 2024.

Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 275% since May 2014, beating its benchmark by 150 percentage points (see more details here).

Is PACS Group Inc. (PACS) The Cheap New Stock To Buy Right Now?

Robert Kneschke/Shutterstock.com

PACS Group Inc. (NYSE:PACS)

Number of Hedge Fund Holders: 32

Forward P/E ratio as of January 25: 7.5

Market Capitalization: $2.21 billion

PACS Group Inc. (NYSE:PACS) provides skilled nursing and senior care services in the US. It operates a network of facilities, which include skilled nursing facilities, assisted living communities, and independent living options.

The company is aggressively expanding its footprint through strategic acquisitions in the post-acute care sector. In November 2024, it acquired 8 facilities in Pennsylvania, which added 1,199 beds and marked its entry into the state. Subsequently, in December 2024, the company acquired 11 facilities in Tennessee, which added 1,310 beds and further expanded its geographic reach to 17 states. PACS Group Inc. (NYSE:PACS) employs a flexible acquisition strategy and uses both lease and purchase models to capitalize on diverse market opportunities. It emphasizes its strong operational performance, with high-quality ratings and above-average occupancy rates across its facilities.

Strategic expansions and acquisitions are expected to drive revenue growth for the company and increase its market share in the post-acute care sector. However, recent analyst reports on the company have seen mixed revisions. Macquarie lowered its price target to $24 from $42 while maintaining an Outperform rating. Truist Financial decreased its target to $32 from $46 but also maintained a Buy rating.

Overall, PACS ranks 3rd on our list of cheap new stocks to buy right now. While we acknowledge the growth potential of PACS, our conviction lies in the belief that AI stocks hold great promise for delivering high returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than PACS but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and Complete List of 59 AI Companies Under $2 Billion in Market Cap

Disclosure: None. This article is originally published at Insider Monkey.